CD200-receptor mediated modulation of bone development

Details for Australian Patent Application No. 2003233721 (hide)

Owner Trillium Therapeutics Inc.

Inventors Gorczynski, Reginald M.

Agent FB Rice

Pub. Number AU-B-2003233721

PCT Number PCT/CA03/00823

PCT Pub. Number WO2003/103709

Priority 60/386,564 07.06.02 US

Filing date 6 June 2003

Wipo publication date 22 December 2003

Acceptance publication date 2 July 2009

International Classifications

A61K 31/00 (2006.01)

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

28 August 2003 Complete Application Filed

  Priority application(s): 60/386,564 07.06.02 US

19 February 2004 Application Open to Public Inspection

  Published as AU-B-2003233721

2 July 2009 Application Accepted

  Published as AU-B-2003233721

29 October 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003233722-Methode and device for pitch enhancement of decoded speech

2003233720-REGULATION OF GENE EXPRESSION USING CHROMATIN REMODELLING FACTORS